IDEXX Laboratories, Inc.

IDXX · NASDAQ

IDEXX reported FY2025 revenue of $4.3 billion and Q1 2026 revenue of $1.1 billion. The thesis depends on companion-animal diagnostics demand, instrument placement, consumables pull-through, margin durability and cash conversion.

Follow Add to Watchlist Ask Question

NASDAQ IDXX Coverage Bootstrap IDEXX Laboratories, Inc.

Member workspace

Financials and workspace tools are for paid members.

Paid login unlocks company financials, filing timeline, peer comparison, scorecard, and discussion. Valuation remains admin-only while we finalize market-data licensing.